The Halcyon™ Platform: Early Adopters Weigh In

Centerline

Early adopters in the U.S., UK, and South Africa report that the Halcyon™ system, optimized for simplified and expedited image-gui...

Read more

New Imaging Technologies Expand Capabilities of Varian’s Halcyon Treatment System

Centerline

Varian has incorporated new imaging technologies in the Halcyon™ treatment system that was first introduced last year. Halcyon 2....

Read more

Calypso Anchored Beacon Lung Transponder Receives FDA Clearance

Centerline

Varian has received FDA 510(k) clearance for its Calypso® Anchored Beacon® transponder, a device that detects even slight movement...

Read more

Eclipse Users Win Top Honors at Treatment Planning World Championships

Centerline

Professionals using Varian’s Eclipse™ treatment planning software placed the highest in the overall category in the first ever Wor...

Read more

Varian Acquires Mobius: A Quality Assurance Software Leader

Centerline

Varian has broadened its ecosystem of cancer care solutions with the acquisition of Mobius Medical Systems, LP, a leader in radiat...

Read more

Varian Acquires Evinance, A Clinical Decision Support Software Company

Centerline

Varian recently acquired Evinance Innovation, Inc., a Montreal-based company focused on developing clinical decision support (CDS)...

Read more

Varian Team’s Two-Part Article Named “Editor’s Choice” by Medical Physics Journal

Centerline

A two-part article authored by Varian-based researchers about the company’s Acuros® CTS, a software tool for scatter correction in...

Read more

Triggered Imaging and Auto Beam Hold: Enhancing Lung SBRT

Centerline

Englewood Hospital and Medical Center is treating small tumors in the lung with SBRT. That in itself isn’t news, but how they are ...

Read more

Early Adopters Find HyperArc Simplifies Delivery of Complex Radiosurgery Treatments for Brain Metastases

Centerline

In 2017, Varian’s HyperArc™ high-definition radiotherapy was used for the first time to treat patients with brain metastases. This...

Read more